Cancer BiologybioRxivPreprint
Tumor-derived biomarkers beyond antigen expression enhance efficacy of CD276/B7H3 antibody-drug conjugate in metastatic prostate cancer
S. Agarwal, L. Fang, K. McGowen…·K. Kelly
This study identifies biomarkers beyond B7H3 expression that predict response to a B7H3-ADC in metastatic prostate cancer models, improving therapeutic efficacy.
DOI 10.1101/2022.04.19.488784